PLUS THERAPEUTICS

WIPO WIPO 2019

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke PLUS THERAPEUTICS wurde als Wortmarke am 11.12.2019 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 06. Juli 2023

Markenform Wortmarke
Aktenzeichen 1524663
Länder Australien Brasilien Kanada China Europäische Gemeinschaft Indonesien Indien Japan Südkorea Mexiko Serbien Russland Türkei
Basismarke US Nr. 88470736, 12. Juni 2019
Anmeldedatum 11. Dezember 2019
Ablaufdatum 11. Dezember 2029

Markeninhaber

4200 Marathon Blvd., Suite 200
Austin TX 78756
US

Markenvertreter

2040 MAIN STREET, 14TH FLOOR US

Waren und Dienstleistungen

05 Nanomedicinal products for medical purposes, namely organic and inorganic pharmaceutical preparations, nanoparticle pharmaceutical preparations, nutraceuticals, pharmaceuticals, pharmaceutical preparations and substances for the prevention and treatment of cancer, diabetes, infectious diseases, autoimmune diseases and disorders, orthopedic diseases and disorders, blood diseases and disorders, fungal infections, diseases and disorders of the central nervous system, oncological diseases and disorders, and ophthalmological diseases and disorders; chemical preparations and reagents for pharmaceutical, medical, and clinical purposes; drug delivery agents in the form of nanoparticle powders that facilitate the delivery of pharmaceutical preparations; liposomal nanoparticle powders being drug delivery agents to facilitate delivery of genetic material and vaccines for medical purposes; all of the aforementioned for human or animal use
40 Providing technical information in the field of pharmaceutical manufacturing; custom manufacture of pharmaceuticals; providing information about custom manufacturing of pharmaceuticals in the nature of oral, inhalatory, intramuscular, intraperitoneal, intratracheal, intratumoral, intravenous, subcutaneous, and topical applied aggregations of liposomes providing time-release of encapsulated pharmaceuticals made to the order or specification of others, for treatment of a wide variety of diseases; custom manufacturing of pharmaceuticals in the nature of oral, inhalatory, intramuscular, intraperitoneal, intratracheal, intratumoral, intravenous, subcutaneous, and topical applied aggregations of liposomes providing time-release of encapsulated pharmaceuticals made to the order or specification of others, for treatment of a wide variety of diseases
42 Drug discovery services; pharmaceutical research and development; research and development of nanomedicinal products; scientific and medical research and development for nutraceuticals, pharmaceuticals, pharmaceutical preparations and substances in the field of cancer, diabetes, infectious diseases, autoimmune diseases and disorders, orthopedic diseases and disorders, blood diseases and disorders, fungal infections, diseases and disorders of the central nervous system, oncological diseases and disorders, and ophthalmological diseases and disorders; scientific research and development for pharmaceuticals in the nature of oral, inhalatory, intramuscular, intraperitoneal, intratracheal, intratumoral intravenous, subcutaneous, and topical applied aggregations of liposomes providing time-release of encapsulated pharmaceuticals, for treatment of a wide variety of diseases; providing medical and scientific information in the aforementioned fields
44 Medical services, namely, administration of nanomedicinal medications; medical services, namely, medical consultancy relating to nanomedicinal products
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
04. Juli 2023 2023/27 Gaz TR Ablehnung
07. Juni 2023 2023/27 Gaz CA RAW: Rule 18ter(2)(ii) GP following a provisional refusal
19. Mai 2022 2022/24 Gaz MX Ablehnung
28. März 2022 2022/18 Gaz IN Ablehnung
04. Oktober 2021 2021/41 Gaz EM Ablehnung
30. September 2021 2021/40 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
10. August 2021 2021/33 Gaz CA Ablehnung
26. Juli 2021 2021/31 Gaz KR Ablehnung
27. Mai 2021 2021/21 Gaz JP Ablehnung
03. Mai 2021 2021/18 Gaz RU Ablehnung
01. März 2021 2021/9 Gaz ID Ablehnung
01. Februar 2021 2021/5 Gaz KR Ablehnung
08. Dezember 2020 2020/52 Gaz BR Ablehnung
09. Oktober 2020 2020/43 Gaz RS Ablehnung
15. September 2020 2020/38 Gaz AU Ablehnung
08. September 2020 2020/38 Gaz RU Ablehnung
20. August 2020 2020/35 Gaz CN Ablehnung
06. Juli 2020 2020/28 Gaz IN Ablehnung
29. April 2020 2020/19 Gaz EM Ablehnung
11. Dezember 2019 2020/13 Gaz US Eintragung

ID: 141524663